Bio-Rad Laboratories Inc. (BUW)
Market Closed
17 Jul, 20:00
XFRA XFRA Primary 
NYSE €
232. 00
+2
+0.8696%
€
5B Market Cap
- P/E Ratio
- Div Yield
5 Volume
11.51 Eps
€ 230
Previous Close Want to track BUW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bio-Rad Laboratories Inc. (BUW) Statistics
Valuation metrics
Market Cap 5B
Enterprise value 4.11B
Trailing P/E (ttm) 36.52
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) 1.93
Price/Book (mrq) 0.86
Enterprise Value/Revenue 1.86
Enterprise Value/EBITDA 10.83
Overview
Shares outstanding 26.83M
Float 20.9M
Shares short -
% Held by insiders 0.98%
% Held by institutions 0%
Average volume (10 days) 2
Average volume (90 days) 2
Price summary
52-Week low 185
52-Week high 282
Beta 1.06
50-Day moving average 208.18
200-Day moving average 225.47
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.07%
Operating margin 0.06%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) 2.21B
Revenue per share (ttm) 95.8
Quarterly revenue growth (yoy) 0.01%
Gross profit (ttm) 1.15B
EBITDA 478.9M
Net income to common (ttm) 144.06M
Diluted EPS (ttm) 5.12
Quarterly earnings growth (yoy) 0.01%
Balance Sheet
Total cash (mrq) 1.34B
Total cash per share (mrq) 58.47
Total debt (mrq) 1.18B
Total Debt/Equity (mrq) 20.12
Current ratio (mrq) 3.21%
Book value per share (mrq) 217.62
Cash Flow
Cash flow statement 435.59M
Levered free cash flow (LFCF) 196.08M
